Uwe Schwengelbeck
13 IP cases indexed. Covers patent matters.
Cases Presided Over
13 cases indexed | Page 1 of 1
Insulet Corporation v.EOFLOW Co., Ltd.
Insulet Corporation applied to the Central Division Milan for the determination of penalty payments against EOFLOW Co., Ltd. for alleged non-compliance with a Court of Appeal Preliminary Injunction (30 April 2025) and a Decision on the Merits (22 July 2025) concerning patent EP4201327 relating to fluid delivery devices such as insulin pumps. EOFLOW argued that the infringing products were supplied by Menarini Diagnostics under a settlement agreement with Insulet, and that the shipments occurred before the Decision on the Merits. The Court ordered EOFLOW to pay EUR 150,000 as a penalty payment and EUR 10,000 in costs.
EOFLOW Co., Ltd. v.Insulet Corporation
This case before the Milan Central Division of the Unified Patent Court concerned a revocation action filed by EOFLOW against Insulet's European patent EP4201327 (relating to a fluid delivery device for insulin pumps), along with Insulet's counterclaim for infringement against EOFLOW's EOPatch/GlucoMen Day Pump. The court addressed issues including the requirements for issuing a decision by default, the interpretation of patent claim language, and the application of cost caps under Article 1(3) of the Administrative Committee's decision. The court ultimately found infringement of claim 1 of EP4201327, issued injunctive relief, ordered information provision, product recall, and damages, with EOFLOW bearing the costs.
Insulet Corporation v.EOFLOW Co., Ltd.
This case before the Milan Central Division of the Unified Patent Court concerned European patent EP4201327 (relating to fluid delivery devices for insulin pumps). EOFLOW sought revocation of the patent, while Insulet filed a counterclaim for infringement based on EOFLOW's EOPatch insulin pump. The Court issued a decision by default against EOFLOW on the revocation action, upheld the patent, found infringement by EOFLOW, and ordered injunctive relief, information disclosure, product recall, and damages with penalty payments for non-compliance.
Belkin Limited, Belkin International, Inc., Belkin GmbH v.Koninklijke Philips N.V.
This is an appeal and cross-appeal before the Court of Appeal of the Unified Patent Court concerning a coercive fine (Zwangsgeld) imposed on Belkin for non-compliance with an information order related to the infringement of Philips' European Patent EP 2 867 997. The Court of Appeal reduced the coercive fine from €46,000 to €42,000, ordered a partial refund, and adjusted the cost allocation between the parties, while rejecting the further-reaching claims of both sides.
EOFLOW Co., Ltd. v.Insulet Corporation
This case before the Milan Central Division of the Unified Patent Court concerned parallel revocation and infringement proceedings regarding European patent EP4201327 (unitary effect EP4201327C0) owned by Insulet Corporation, relating to fluid delivery devices for insulin pumps. EOFLOW sought revocation of the patent for lack of novelty and inventive step, while Insulet counterclaimed for infringement based on EOFLOW's EOPatch/GlucoMen Day Pump product. The Court revoked the patent in its entirety for lack of novelty and inventive step, and issued a decision by default against EOFLOW on the infringement counterclaim due to its failure to file a Reply, ordering injunctive relief, information disclosure, product recall, and damages with penalty payments.
EOFLOW Co., Ltd. v.Insulet Corporation
This is a procedural order from the Central Division of the Unified Patent Court in Milan concerning a revocation action filed by EOFLOW Co., Ltd. against Insulet Corporation's European Patent EP4201327, which relates to fluid delivery devices for insulin management. The court dismissed EOFLOW's request for further written submissions, declared US patent 6656159 (Flaherty) inadmissible as late-filed prior art, and ordered EOFLOW to provide EUR 500,000 as security for costs within three weeks.
Insulet Corporation v.A. Menarini Diagnostics s.r.l.
Insulet Corporation sought provisional measures from the Milan Local Division of the Unified Patent Court against A. Menarini Diagnostics, alleging infringement of European patent EP 4 201 327 through the sale of the EOPatch/GlucoMen Day Pump insulin patch pump. The Court dismissed the application, finding that Insulet failed to demonstrate with sufficient certainty that the patent was valid and infringed, and that the balance of interests did not favor granting the injunction. Insulet was ordered to pay EUR 117,465.00 as interim costs.
Insulet Corporation v.EOFLOW Co., Ltd.
Insulet Corporation, owner of European Patent EP4201327 concerning a fluid delivery device (insulin pump), sought a preliminary injunction against EOFLOW Co., Ltd. alleging that EOFLOW's 'EOPatch' insulin pump infringed its patent. The Court of First Instance of the Unified Patent Court (Milan Central Division) denied the application for provisional measures, finding significant doubts regarding the validity of the patent in light of prior art (US'994), which appeared to disclose all features of claim 1. The applicant was ordered to bear the costs of the proceedings.
Koninklijke Philips N.V. v.Belkin Limited, Belkin GmbH, Belkin International, Inc. and Others
Koninklijke Philips N.V. sued Belkin entities and their directors for infringement of European Patent EP 2 867 997 concerning inductive power transmission systems. The Local Division Munich found infringement and ordered remedies against both the corporate entities and their managing directors. Belkin appealed and sought suspensive effect of the appeal. The Court of Appeal partially granted the request, ordering suspensive effect only with respect to enforcement against the individual directors, holding that a managing director of an infringing company cannot be considered a 'third party' under Article 63 EPGÜ for intermediary liability purposes.
A. Menarini Diagnostics s.r.l. v.Insulet Corporation
This procedural order concerns an application by EOFLOW Co Ltd to intervene under Rule 313 RoP in provisional measures proceedings brought by Insulet Corporation against A. Menarini Diagnostics s.r.l. concerning alleged infringement of European Patent EP 4201327 relating to a patch-insulin pump. The Milan Local Division dismissed the application to intervene, holding that the balance of interests favored a speedy decision in the interim proceedings, that Eoflow's arguments were already being addressed in parallel proceedings before the Milan Central Division, and that the provisional measures would only affect Eoflow indirectly.
Insulet Corporation v.EOFLOW Co. Ltd (Request for Intervention by A. Menarini Diagnostics s.r.l.)
This procedural order from the Central Division Milan of the Unified Patent Court concerns a request by A. Menarini Diagnostics s.r.l. to intervene in provisional measures proceedings brought by Insulet Corporation against EOFLOW Co. Ltd regarding European Patent EP4201327. The Court first overruled Insulet's preliminary objection that the intervention application was inadmissible because it was filed in hard copy rather than electronically, finding that the CMS lacked a workflow for third-party interventions. On the merits, the Court rejected the intervention request, holding that intervention in interim injunction proceedings is only available in exceptional cases and that Menarini could adequately protect its interests in parallel proceedings before the Local Division Milan.
Insulet Corporation v.A. Menarini Diagnostics s.r.l. (Eoflow Co Ltd Intervention)
Eoflow Co Ltd applied to intervene in provisional measures proceedings brought by Insulet Corporation against A. Menarini Diagnostics concerning alleged infringement of EP 4201327 (a patch-insulin pump patent). The Milan Local Division dismissed the application to intervene, holding that the efficiency of the interim proceedings and the applicant's interest in a speedy decision outweighed Eoflow's interest in intervening, particularly since Eoflow was already a defendant in parallel infringement proceedings before the Milan Central Division.
A. Menarini Diagnostics s.r.l. v.Insulet Corporation
This procedural order from the Milan Local Division concerns A. Menarini Diagnostics' request to classify certain portions of its Objection to an Application for provisional measures as confidential information. The Court granted confidentiality protection to both the technical descriptions of the Attacked Embodiment and Menarini's business figures, while establishing a restricted confidentiality club for access. The Court deferred the enforceability of the order to allow time for appeal.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.